{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:13:12Z","timestamp":1791274392180,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.neurobiolaging.2012.02.023","type":"journal-article","created":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T04:46:04Z","timestamp":1332305164000},"page":"2942-2947","source":"Crossref","is-referenced-by-count":31,"title":["Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Dongzi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongeun J.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib1","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1084\/jem.172.5.1521","article-title":"Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system","volume":"172","author":"Cannella","year":"1990","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib2","first-page":"23","article-title":"Adhesion-related molecules in the central nervous system","volume":"65","author":"Cannella","year":"1991","journal-title":"Lab. Invest"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0165-5728(91)90183-8","article-title":"Relapsing autoimmune demyelination: a role for vascular addressins","volume":"35","author":"Cannella","year":"1991","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2006.03.007","article-title":"Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis","volume":"175","author":"Chaudhary","year":"2006","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-60761-744-0_13","article-title":"Selecting a mouse model of Alzheimer's disease","volume":"670","author":"Chin","year":"2011","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib6","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.83.23.9114","article-title":"Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic","volume":"83","author":"Duijvestijn","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-5728(94)90082-5","article-title":"Cell adhesion molecules on vessels during inflammation in the mouse central nervous system","volume":"51","author":"Engelhardt","year":"1994","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib9","doi-asserted-by":"crossref","unstructured":"Ferretti, M.T., Bruno, M.A., Ducatenzeiler, A., Klein, W.L., Cuello, A.C., in press. Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer's disease. Neurobiol. Aging [PubMed: 21414686].","DOI":"10.1016\/j.neurobiolaging.2011.01.007"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-8-26","article-title":"Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease","volume":"8","author":"Grammas","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1212\/01.wnl.0000265223.25679.2a","article-title":"Does NSAID use modify cognitive trajectories in the elderly?","volume":"69","author":"Hayden","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-2-23","article-title":"Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice","volume":"2","author":"Janelsins","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/brain\/awn008","article-title":"Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity","volume":"131","author":"Kotilinek","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib16","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease","volume":"20","author":"Lim","year":"2000","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0197-4580(01)00299-8","article-title":"Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice","volume":"22","author":"Lim","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20070304","article-title":"Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease","volume":"204","author":"Paul","year":"2007","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-8454-2-8","article-title":"The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis","volume":"2","author":"Schulz","year":"2005","journal-title":"Cerebrospinal Fluid Res"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbadis.2009.10.013","article-title":"Inflammation in transgenic mouse models of neurodegenerative disorders","volume":"1802","author":"Schwab","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1749-6632.2000.tb06384.x","article-title":"Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation","volume":"903","author":"Sparks","year":"2000","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nn.2947","article-title":"Cerebrovascular disorders: molecular insights and therapeutic opportunities","volume":"14","author":"Storkebaum","year":"2011","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000078501","article-title":"Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review","volume":"23","author":"Szekely","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(01)01592-0","article-title":"Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576","volume":"301","author":"Tehranian","year":"2001","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib26","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1172\/JCI39716","article-title":"NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease","volume":"119","author":"Varvel","year":"2009","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib28","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib29","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2012.02.023_bib30","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI37914","article-title":"Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis","volume":"119","author":"Yang","year":"2009","journal-title":"J. Clin. Invest"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T21:54:24Z","timestamp":1561499664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0197458012001728"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.02.023","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}